Is an estradiol (E2) level of 10.5 pg/mL indicative of postmenopause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

An estradiol level of 10.5 pg/mL is consistent with postmenopausal status in women. Typically, postmenopausal estradiol levels range from less than 10 pg/mL to about 20 pg/mL, while premenopausal women generally have levels between 30-400 pg/mL, depending on the phase of their menstrual cycle. The value of 10.5 pg/mL indicates reduced ovarian function and estrogen production, which occurs naturally during menopause. This low estradiol level explains many common menopausal symptoms such as hot flashes, vaginal dryness, and bone density changes.

Some key points to consider:

  • Estradiol levels can vary widely among postmenopausal women, and a level of 10.5 pg/mL is within the expected range for this population 1.
  • The use of selective estrogen receptor modulators (SERMs) such as raloxifene and bazedoxifene may be considered for the prevention and treatment of postmenopausal osteoporosis, as they have been shown to reduce the risk of vertebral fractures and have a favorable safety profile compared to traditional hormone replacement therapy 2.
  • However, SERMs may not be effective in reducing climacteric symptoms such as hot flashes, and may be associated with an increased risk of venous thromboembolic events 2.
  • The combination of bazedoxifene with conjugated estrogens (BZA/CE) has been shown to be effective in reducing the severity and frequency of hot flashes, improving vaginal atrophy, and increasing bone mineral density, while also preventing endometrial proliferation 2.
  • It's essential to interpret the estradiol level in context with other hormones like FSH (which would be elevated in menopause) and the woman's clinical presentation, including absence of menstrual periods for 12 consecutive months.

In terms of management, hormone replacement therapy (HRT) or alternative treatments such as SERMs may be considered for women with significant menopausal symptoms and low estradiol levels, after discussing the risks and benefits with a healthcare provider. The goal of treatment is to alleviate symptoms, prevent osteoporosis, and improve quality of life, while minimizing the risks of adverse effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.